Helius Medical Technologies (HSDT) Stock Price, News & Analysis

Company Overview

Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company was incorporated in 2014 and is headquartered in Newtown, Pennsylvania.

Key Stats

• Today's Range: $0.69 to $0.76
• 50-Day Range: $0.43 to $1.02
• 52-Week Range: $0.37 to $9.50
• Volume: 115,592 shs
• Average Volume: 182,587 shs
• Market Capitalization: $2.65 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $24.00
• Consensus Rating: Moderate Buy

Helius Medical Technologies Stock Analysis - MarketRank™

Helius Medical Technologies scored higher than 32% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.3 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Helius Medical Technologies has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.

Amount of Analyst Coverage

Helius Medical Technologies has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Helius Medical Technologies is -0.11, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Helius Medical Technologies is -0.11, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Helius Medical Technologies has a P/B Ratio of 0.21. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

4.28% of the outstanding shares of Helius Medical Technologies have been sold short.

Short Interest Ratio / Days to Cover

Helius Medical Technologies has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Helius Medical Technologies has recently increased by 77.51%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Helius Medical Technologies does not currently pay a dividend.

Dividend Growth

Helius Medical Technologies does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

4.28% of the outstanding shares of Helius Medical Technologies have been sold short.

Short Interest Ratio / Days to Cover

Helius Medical Technologies has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Helius Medical Technologies has recently increased by 77.51%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 1.1 / 5
• News Sentiment: N/A

Search Interest

1 people have searched for HSDT on MarketBeat in the last 30 days.

MarketBeat Follows

3 people have added Helius Medical Technologies to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Helius Medical Technologies insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 5.10% of the stock of Helius Medical Technologies is held by insiders.

Percentage Held by Institutions

Only 18.63% of the stock of Helius Medical Technologies is held by institutions.

HSDT Stock Analysis - Frequently Asked Questions

How have HSDT shares performed this year?

Helius Medical Technologies' stock was trading at $0.6703 at the beginning of the year. Since then, HSDT stock has increased by 4.3% and is now trading at $0.6990.
View the best growth stocks for 2025 here.

How were Helius Medical Technologies' earnings last quarter?

Helius Medical Technologies, Inc. (NASDAQ:HSDT) announced its quarterly earnings results on Monday, August, 12th. The company reported ($0.64) earnings per share for the quarter, missing the consensus estimate of ($0.50) by $0.14. The business had revenue of $0.18 million for the quarter. Helius Medical Technologies had a negative net margin of 1,764.74% and a negative trailing twelve-month return on equity of 244.82%.

When did Helius Medical Technologies' stock split?

Helius Medical Technologies's stock reverse split on the morning of Thursday, August 17th 2023. The 1-50 reverse split was announced on Thursday, August 17th 2023. The number of shares owned by shareholders was adjusted after the market closes on Thursday, August 17th 2023. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split.

How do I buy shares of Helius Medical Technologies?

Shares of HSDT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Helius Medical Technologies own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Helius Medical Technologies investors own include HubSpot (HUBS), Mazor Robotics (MZOR), Netflix (NFLX), Riot Platforms (RIOT), Tesla (TSLA), Acasti Pharma (ACST) and Domino's Pizza (DPZ).

Company Calendar

• Last Earnings: 8/12/2024
• Today: 1/07/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Electromedical equipment
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:HSDT
• CUSIP: N/A
• CIK: 1610853
• Web: heliusmedical.com
• Phone: (877) 564-0008
• Fax: N/A
• Employees: 30
• Year Founded: 2014

Price Target and Rating

• Average Stock Price Target: $24.00
• High Stock Price Target: $24.00
• Low Stock Price Target: $24.00
• Potential Upside/Downside: +3,333.5%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.50
• Research Coverage: 2 Analysts

Profitability

• EPS (Most Recent Fiscal Year): ($6.18)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-8,850,000.00
• Net Margins: -1,764.74%
• Pretax Margin: -1,764.74%
• Return on Equity: -244.82%
• Return on Assets: -127.10%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 3.61
• Quick Ratio: 3.10

Sales & Book Value

• Annual Sales: $502,000.00
• Price / Sales: 5.19
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $3.32 per share
• Price / Book: 0.21

Miscellaneous

• Outstanding Shares: 3,728,000
• Free Float: 3,538,000
• Market Cap: $2.61 million
• Optionable: Not Optionable
• Beta: 1.47